Sales are steadily improving at Coca-Cola Co. as vaccinations allow for the opening of stadiums, restaurants and theaters in many regions globally.
Sales rose 5% in the January-March period this year, the Atlanta company said Monday, helped by strong growth in China and India. But the recovery is uneven. Case volume declined in North America and Europe, where many dining rooms and other venues remain closed.
Net income dropped 19% to $2.2 billion in the first quarter. Excluding one-time items, the company earned 55 cents per share. That exceeded Wall Street’s forecast of 50 cents, according to analysts polled by FactSet.
Coke’s revenue rose 5% to $9.0 billion, ahead of the $8.6 billion analysts had forecast.
Before you consider CocaCola, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CocaCola wasn't on the list.
While CocaCola currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
